サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1795335

関節リウマチ診断機器の世界市場

Rheumatoid Arthritis Diagnostic Devices

出版日
ページ情報
英文 170 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.92円
関節リウマチ診断機器の世界市場
出版日: 2025年08月21日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 170 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

関節リウマチ診断機器の世界市場は2030年までに5億9,170万米ドルに達する見込み

2024年に4億7,750万米ドルと推定される関節リウマチ診断機器の世界市場は、2024年から2030年にかけてCAGR 3.6%で成長し、2030年には5億9,170万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである分析装置は、CAGR 4.3％を記録し、分析期間終了時には4億1,950万米ドルに達する見込みです。消耗品セグメントの成長率は、分析期間中CAGR 2.1％と推定されます。

米国市場は1億3,010万米ドルと推定、中国はCAGR6.9％で成長予測

米国の関節リウマチ診断機器市場は、2024年には1億3,010万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.9%として、2030年までに1億1,960万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.4%と2.8%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の関節リウマチ診断機器市場- 主要動向と促進要因のまとめ

顕微鏡で見る早期発見：診断デバイスはRA管理の将来をどのように形成するか

関節リウマチにおける早期かつ正確な診断の需要を牽引するものは何か？

世界人口の約1％が罹患している慢性自己免疫疾患である関節リウマチ（RA）の世界の負担の増加は、迅速で正確、かつ利用しやすい診断ツールの必要性を促しています。RAは進行性で不可逆的な関節障害であるため、長期的な障害を予防し、患者のQOLを改善し、経済的負担を軽減するためには早期診断が必要です。しかし、従来の診断スケジュールでは、症状発現から臨床的確認まで6ヵ月以上の遅れが生じることが多いです。このギャップにより、RAを早期に発見し、他の関節炎や筋骨格系疾患と区別できる診断機器に対する大きな需要が生じています。

従来のRAの診断には、臨床評価、リウマトイド因子（RF）抗体や抗環状シトルリン化ペプチド（抗CCP）抗体の検査、X線やMRIなどの画像診断が一般的でした。しかし、これらの手段は、早期病期においては感度や特異性に限界があることが多いです。これに対し、RA診断を迅速化し強化するために、マルチプレックスバイオマーカー検出、ポイントオブケア（POC）機能、高度な画像診断アルゴリズムを組み込んだ次世代診断機器の開発が進められています。血清学的、分子学的、画像診断技術の融合は、一次、二次、三次医療において、より個別化されたデータ主導型の診断プロトコルの基礎を築きつつあります。

バイオマーカー、画像診断、ポイントオブケア機器の革新はRA診断をどのように再定義しているか？

RA診断における技術的進歩は、疾患検出の精度、スピード、アクセシビリティの拡大に焦点を当てています。ELISAプラットフォームやマイクロ流体検査カートリッジなどのバイオマーカーに基づくイムノアッセイ装置は、現在では1回の血液サンプルから複数のバイオマーカー（RF、抗CCP、CRP、ESR、14-3-3ηタンパク質）を検出することができます。これらのマルチプレックスアッセイは、特に早期あるいは血清陰性のRA症例において診断感度を向上させています。高スループットのラボ用分析装置は、臨床症状が完全に顕在化する前であっても、早期RAを示すパターンにフラグを立てるために、AIを駆使した分析と統合されつつあります。一方、携帯型のPOC分析装置は、プライマリケアや地域の診療所で普及しつつあり、医師が数分以内にRAを確認したり除外したりできるようになっています。

高度な画像診断技術も重要な役割を果たしています。ドップラー機能を備えた筋骨格系超音波（MSUS）は、滑膜炎症の評価、生検の誘導、疾患の進行モニタリングにますます使用されるようになっています。進行した段階でのみ構造的損傷を明らかにするX線とは異なり、超音波とMRIは滑膜炎と骨髄浮腫を疾患の初期段階で検出することができます。AIによる画像強調や自動関節スコアリング機能を備えた機器は診断精度を高め、専門的なトレーニングを受けていない臨床医でも画像診断結果を効果的に解釈できるようになっています。さらに、検査データと画像データをソフトウェアで統合して診断意思決定支援システムを構築することは、病院環境で一般的になりつつあり、早期介入戦略を支援しています。

さらに、機器の小型化とスマートフォンとの統合により、家庭での使用や遠隔地でのリウマチ診療のための携帯型診断システムの開発が加速しています。関節の動きや温度、間質液中の炎症マーカーを連続的にモニターするウェアラブルバイオセンサーは実験段階にあり、近い将来、従来の診断法を補完するものとなると思われます。これらの技術革新は、疾患活動性をより継続的に実世界で把握し、治療介入のタイミングを改善することを目的としています。

地域のヘルスケアインフラと診断経路は機器導入にどのような影響を与えるか？

RA診断機器の導入は、地域のヘルスケアインフラ、疾患認知度、専門医療へのアクセスに大きく影響されます。米国、ドイツ、日本、英国などの高所得国では、保険が適用され、リウマチ科のネットワークが充実しているため、早期の診断が容易です。これらの地域の診断検査室は多くの場合、全自動免疫測定分析装置で運営されており、病院は高度な画像診断装置を備えています。臨床ガイドラインでは早期の紹介と診断が重視されており、高精度の検査・画像診断ソリューションに対する需要が着実に高まっています。さらに、これらの地域の医療システムは電子カルテ（EMR）に診断法を積極的に組み込んでおり、縦断的な疾病追跡と研究を可能にしています。

一方、新興国では、RA診断の状況はより断片的です。インド、ブラジル、インドネシアなどでは、認知度の低さ、リウマチ専門医の不足、高度な検査へのアクセスの少なさなどから、診断の遅れが依然として一般的です。しかし、モバイルPOC診断機器は、これらの状況において重要なソリューションとして台頭してきており、診断を分散化し、都市と農村の格差を縮小するのに役立っています。慢性疾患の発見に焦点を当てた政府のイニシアティブや官民のパートナーシップも、プライマリーヘルスセンターに基本的な診断インフラを装備するのに役立っています。

診断機器ベンダーの役割は、こうした地域の課題に応じて変化しています。メーカー各社は、集中ラボ、サテライトクリニック、遠隔スクリーニングキャンプに適応できる拡張性のある機器プラットフォームを提供しています。また、遠隔医療プロバイダーとの提携により、画像のアップロードや血清学的検査結果の自動フラグ付けに対応したリウマチ専門医による遠隔診断評価が可能になっています。さらに、早期診断によるコスト削減を裏付ける医療経済的エビデンスが、支払者や政策立案者に診断イノベーションへの投資を促しています。

関節リウマチ診断機器市場の長期的成長の原動力は？

関節リウマチ診断機器市場の成長の原動力は、疾患有病率の増加、RAの病態生理の理解向上、ヘルスケア業界の早期介入と個別化医療への軸足です。最も強力な促進要因の1つは、疾患修飾性抗リウマチ薬（DMARDs）をできるだけ早期に、理想的には症状発現から最初の3カ月以内に開始する必要性です。診断の遅れを短縮し、早期RAを確認できる診断機器は、この臨床目標を達成するための中心的存在です。

加えて、価値観に基づいた医療を目指す動きは、診断精度とリスク層別化ツールに対する要求を増幅させています。支払者や医療提供者が長期的な障害、入院、薬剤費の削減を目指す中、疾患の進行や治療反応に関する予測的洞察を提供する機器への関心が高まっています。予後バイオマーカーパネルを含む、あるいは治療アルゴリズムと統合された診断プラットフォームは、RAにおける精密医療を実現するものとして位置づけられています。

最後に、遠隔医療、モバイルクリニック、在宅モニタリングに後押しされた分散型遠隔診断の台頭は、RA検査の範囲を専門クリニックを超えて拡大しています。デジタルヘルスエコシステムと互換性のある低価格で迅速な検査機器は、集団スクリーニング、職場の健康プログラム、慢性疾患のアウトリーチイニシアチブを可能にしています。医療システムが世界的に早期介入、コスト抑制、慢性疾患管理に注力する中、関節リウマチ診断機器は持続的なイノベーションと市場浸透の態勢を整えています。

セグメント

製品タイプ（分析装置、消耗品）

調査対象企業の例

  • Abbott Laboratories
  • AESKU.GROUP
  • Antibodies Inc.
  • Augurex Life Sciences Corp.
  • Autobio Diagnostics
  • Axis-Shield PLC
  • Beckman Coulter（Danaher Corp.）
  • Bio-Rad Laboratories, Inc.
  • Biopanda Reagents Ltd.
  • Boditech Med Inc.
  • Euro Diagnostica AB
  • Exagen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Getein Biotech, Inc.
  • Labcorp（Laboratory Corporation of America Holdings）
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • Randox Laboratories
  • Siemens Healthineers AG
  • Svar Life Science AB
  • Teco Diagnostics
  • Thermo Fisher Scientific Inc.
  • Tulip Diagnostics（P）Ltd.

AIインテグレーション

検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革します。

Global Industry Analystsは、一般的なLLMや業界固有のSLMをクエリする代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37926

Global Rheumatoid Arthritis Diagnostic Devices Market to Reach US$591.7 Million by 2030

The global market for Rheumatoid Arthritis Diagnostic Devices estimated at US$477.5 Million in the year 2024, is expected to reach US$591.7 Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Analyzers, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$419.5 Million by the end of the analysis period. Growth in the Consumables segment is estimated at 2.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$130.1 Million While China is Forecast to Grow at 6.9% CAGR

The Rheumatoid Arthritis Diagnostic Devices market in the U.S. is estimated at US$130.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$119.6 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Rheumatoid Arthritis Diagnostic Devices Market - Key Trends & Drivers Summarized

Early Detection Under the Microscope: How Diagnostic Devices Are Shaping the Future of RA Management

What Is Driving the Demand for Early and Accurate Diagnosis in Rheumatoid Arthritis?

The rising global burden of rheumatoid arthritis (RA), a chronic autoimmune condition affecting approximately 1% of the global population, is driving the need for rapid, accurate, and accessible diagnostic tools. RA’s progressive nature and irreversible joint damage necessitate early diagnosis to prevent long-term disability, improve patient quality of life, and reduce the economic burden of care. Yet, conventional diagnostic timelines often lead to delays of six months or more between symptom onset and clinical confirmation. This gap has created significant demand for diagnostic devices that can detect RA earlier in its course and distinguish it from other forms of arthritis or musculoskeletal disorders.

Traditional diagnostic pathways for RA typically involve clinical evaluation, laboratory testing for rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies, and imaging modalities such as X-ray or MRI. However, these tools are often limited by sensitivity or specificity in early disease stages. In response, next-generation diagnostic devices are being developed to incorporate multiplex biomarker detection, point-of-care (POC) capabilities, and advanced imaging algorithms to accelerate and enhance RA diagnosis. The convergence of serological, molecular, and imaging technologies is laying the foundation for more personalized and data-driven diagnostic protocols across primary, secondary, and tertiary care settings.

How Are Innovations in Biomarkers, Imaging, and Point-of-Care Devices Redefining RA Diagnostics?

Technological advancements in RA diagnostics are focused on expanding the accuracy, speed, and accessibility of disease detection. Biomarker-based immunoassay devices, such as ELISA platforms and microfluidic test cartridges, are now capable of detecting multiple biomarkers-RF, anti-CCP, CRP, ESR, and 14-3-3η protein-from a single blood sample. These multiplex assays are improving diagnostic sensitivity, particularly in early or seronegative RA cases. High-throughput lab analyzers are being integrated with AI-powered analytics to flag patterns indicative of early RA, even before clinical symptoms fully manifest. Meanwhile, portable POC analyzers are gaining traction in primary care and community clinics, allowing physicians to confirm or rule out RA within minutes.

Advanced imaging technologies are also playing a critical role. Musculoskeletal ultrasound (MSUS) with Doppler capabilities is increasingly used for assessing synovial inflammation, guiding biopsies, and monitoring disease progression. Unlike X-rays, which only reveal structural damage in advanced stages, ultrasound and MRI can detect synovitis and bone marrow edema early in the disease. Devices with AI-based image enhancement and automated joint scoring are enhancing diagnostic precision and enabling clinicians with less specialized training to interpret imaging results effectively. Moreover, software-assisted integration of lab and imaging data into diagnostic decision-support systems is becoming common in hospital settings, supporting early intervention strategies.

Furthermore, device miniaturization and smartphone integration are fueling the development of portable diagnostic systems for home use and remote rheumatology services. Wearable biosensors that continuously monitor joint movement, temperature, or inflammatory markers in interstitial fluid are in experimental phases and could soon supplement traditional diagnostics. These innovations aim to create a more continuous, real-world understanding of disease activity and improve the timing of therapeutic interventions.

How Do Regional Healthcare Infrastructure and Diagnostic Pathways Impact Device Adoption?

The adoption of RA diagnostic devices is heavily influenced by local healthcare infrastructure, disease awareness levels, and access to specialized care. In high-income countries like the U.S., Germany, Japan, and the U.K., robust insurance coverage and rheumatology networks facilitate early diagnostic workups. Diagnostic laboratories in these regions often operate with fully automated immunoassay analyzers, and hospitals are equipped with advanced imaging modalities. Clinical guidelines emphasize early referral and diagnosis, creating a steady demand for high-accuracy lab and imaging solutions. Moreover, health systems in these regions are actively integrating diagnostics into electronic medical records (EMRs), enabling longitudinal disease tracking and research.

In contrast, emerging economies face a more fragmented RA diagnostic landscape. In countries such as India, Brazil, and Indonesia, delayed diagnosis remains common due to lack of awareness, limited rheumatology specialists, and minimal access to advanced testing. However, mobile POC diagnostic devices are emerging as a critical solution in these contexts, helping to decentralize diagnosis and reduce urban-rural disparities. Government initiatives focused on chronic disease detection, along with public-private partnerships, are also helping to equip primary health centers with basic diagnostic infrastructure.

The role of diagnostic device vendors is shifting in response to these regional challenges. Manufacturers are offering scalable device platforms that can be adapted for centralized labs, satellite clinics, or remote screening camps. Partnerships with telemedicine providers are also enabling remote diagnostic evaluations by rheumatologists, supported by imaging uploads and auto-flagged serological test results. Additionally, health economic evidence supporting cost savings from early diagnosis is influencing payers and policymakers to invest in diagnostic innovation.

What Is Driving Long-Term Growth in the Rheumatoid Arthritis Diagnostic Devices Market?

The growth in the rheumatoid arthritis diagnostic devices market is driven by increasing disease prevalence, improved understanding of RA pathophysiology, and the healthcare industry’s pivot toward early intervention and personalized care. One of the strongest growth drivers is the need to initiate disease-modifying antirheumatic drugs (DMARDs) as early as possible, ideally within the first three months of symptom onset. Diagnostic devices that can shorten the diagnostic delay and confirm early-stage RA are central to achieving this clinical target.

Additionally, the movement toward value-based care is amplifying demand for diagnostic accuracy and risk stratification tools. As payers and providers aim to reduce long-term disability, hospitalization, and drug expenditure, there is growing interest in devices that offer predictive insights into disease progression and therapeutic response. Diagnostic platforms that include prognostic biomarker panels or integrate with treatment algorithms are being positioned as enablers of precision medicine in RA.

Finally, the rise of decentralized and remote diagnostics-fueled by telehealth, mobile clinics, and home-based monitoring-is expanding the reach of RA testing beyond specialty clinics. Low-cost, rapid test devices compatible with digital health ecosystems are enabling population screening, workplace health programs, and chronic disease outreach initiatives. As health systems globally focus on early intervention, cost containment, and chronic disease management, rheumatoid arthritis diagnostic devices are poised for sustained innovation and market penetration.

SCOPE OF STUDY:

The report analyzes the Rheumatoid Arthritis Diagnostic Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Analyzers, Consumables)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • AESKU.GROUP
  • Antibodies Inc.
  • Augurex Life Sciences Corp.
  • Autobio Diagnostics
  • Axis-Shield PLC
  • Beckman Coulter (Danaher Corp.)
  • Bio-Rad Laboratories, Inc.
  • Biopanda Reagents Ltd.
  • Boditech Med Inc.
  • Euro Diagnostica AB
  • Exagen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Getein Biotech, Inc.
  • Labcorp (Laboratory Corporation of America Holdings)
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • Randox Laboratories
  • Siemens Healthineers AG
  • Svar Life Science AB
  • Teco Diagnostics
  • Thermo Fisher Scientific Inc.
  • Tulip Diagnostics (P) Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Rheumatoid Arthritis Diagnostic Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Global Autoimmune Disease Incidence Propels Demand for Early Diagnostic Tools
    • Emphasis on Early Disease Detection and Prognosis Strengthens Business Case for RA Diagnostics
    • Expansion of Rheumatology Services Across Primary Care Settings Spurs Point-of-Care Test Adoption
    • Growth in Biologic and Targeted Therapy Approvals Increases Demand for Diagnostic Stratification
    • Integration of Biomarker-Based Immunoassays Enhances Test Specificity and Disease Monitoring
    • Expansion of Multiplex Testing Platforms Enables Simultaneous Detection of Autoantibody Panels
    • Improved Sensitivity in Anti-CCP and RF Assays Fuels Market Penetration in Early RA Detection
    • Development of Lab-on-Chip and Microfluidic Devices Spurs Innovation in Compact Diagnostic Formats
    • Increased Adoption of Automated Analyzers Enhances Laboratory Workflow Efficiency
    • Growing Prevalence of Joint Pain and Non-Specific Symptoms Expands Screening Population
    • Availability of Home Sample Collection Kits Drives Remote Patient Diagnostics
    • Collaborations Between Pharma and Diagnostic Firms Propel Companion Diagnostic Development
    • Clinical Research in Predictive RA Markers Expands Scope of Molecular Diagnostic Devices
    • Advancements in AI-Based Image Analysis Bolster Demand for Ultrasound and MRI-Based RA Evaluation
    • Increased Use of CRP and ESR Point-of-Care Tests Strengthens Early Inflammatory Profiling
    • Government Investments in Autoimmune Disease Management Programs Support Infrastructure Upgrades
    • Greater Patient Awareness of Autoimmune Symptoms Accelerates Screening Test Volumes
    • Push for Personalized Medicine Drives Growth in Diagnostic Segmentation Tools
    • Expanded Insurance Coverage for Early Diagnostic Testing Enhances Patient Access
    • Regulatory Approvals of Novel RA Biomarker Panels Stimulate Commercial Adoption Across Key Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Rheumatoid Arthritis Diagnostic Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • JAPAN
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • CHINA
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: China 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • EUROPE
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • FRANCE
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: France 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • GERMANY
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • INDIA
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: India 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030
  • AFRICA
    • Rheumatoid Arthritis Diagnostic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Rheumatoid Arthritis Diagnostic Devices by Product Type - Analyzers and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Rheumatoid Arthritis Diagnostic Devices by Product Type - Percentage Breakdown of Value Sales for Analyzers and Consumables for the Years 2014, 2025 & 2030

IV. COMPETITION